SCHEMBL5497723

SCHEMBL5497723

CC(C)(CCC(=O)O)NC=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAALAD2 Q9Y3Q0 1/20 0.44
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
THRB P10828 1/20 0.36
KMT2A Q03164 1/20 0.36
ESR1 P03372 1/20 0.36
CYP3A4 P08684 1/20 0.36
ESR2 Q92731 1/20 0.36
PKM P14618 1/20 0.34
EGLN1 Q9GZT9 3/20 0.33
LMNA P02545 3/20 0.33
TSHR P16473 2/20 0.33
FFAR3 O14843 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
CYP2C9 P11712 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21841834 0.80 NAALAD2 (0.33) NAALAD2TSHR
SCHEMBL14314438 0.77 NAALAD2 (0.38) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL9479833 0.77 HMGCR (0.44) ALDH1A1CYP3A4PKMTSHRCYP2C9
SCHEMBL3993911 0.77 NAALAD2 (0.50) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL28059709 0.76 NAALAD2 (0.39) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL16153007 0.75 NAALAD2 (0.48) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL8763149 0.74 PKM (0.31) PKM
SCHEMBL269676 0.72
SCHEMBL22297100 0.71 KDM4E (0.42) PKMTSHRHIF1AKDM4EFFAR1
SCHEMBL10722886 0.70 ALDH1A1 (0.44) NAALAD2ALDH1A1MEN1CYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276484-B2 Dipeptide inhibitors of β-secretase ELAN PHARMACEUTICALS, INC. (US) 2007-10-02 US disclosed
US-20050182138-A1 Dipeptide inhibitors of beta-secretase ELAN PHARMACEUTICALS, INC. 2005-08-18 US disclosed
US-6864240-B1 Dipeptide inhibitors of β-secretase ELAN PHARMACEUTICALS, INC. (US) 2005-03-08 US disclosed
US-4988827-A Radioimaging of myocardial tissues E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-01-29 US disclosed
EP-0233368-B1 ETHER ISONITRILES AND RADIOLABELED COMPLEXES THEREOF DU PONT (US) 1990-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182138-A1 Dipeptide inhibitors of beta-secretase BACE1, APP, BACE2 NAALAD2 19/4885ALDH1A1 3256/4885MEN1 2039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.